Anticancer and Antimicrobial Activities of Naproxen and Naproxen Derivatives
- 1 January 2020
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Mini-Reviews in Medicinal Chemistry
- Vol. 20 (13), 1300-1310
- https://doi.org/10.2174/1389557520666200505124922
Abstract
This review explains the effects of naproxen and the naproxen moiety in important biological activities. Naproxen, 2-(6-methoxynaphthalen-2-yl)propionic acid, is one of the most utilized propionic acid derivatives to the cure of many injuries or pains. Naproxen is a non-steroidal anti-inflammatory drug (NSAID), which is generally used among the NSAIDs. Even though it has gastrointestinal side effects, naproxen has been safely used for many years because of the good cardiovascular sight. In the past years, except for anti-inflammatory effects, other pharmacological activities of naproxen, especially anticancer and antimicrobial activities, gain the attention of researchers. Naproxen shows its activity by inhibiting the COX-2 enzyme. There is significant interest in the possibility that COX-2 inhibitors might retard or prevent the development of various cancer types, which is often characterized by COX-2 expression. The activities of both naproxen and new molecules derived from naproxen were frequently investigated.Keywords
This publication has 60 references indexed in Scilit:
- Structure-Based Discovery of the Novel Antiviral Properties of Naproxen against the Nucleoprotein of Influenza A VirusAntimicrobial Agents and Chemotherapy, 2013
- Combination of Atorvastatin with Sulindac or Naproxen Profoundly Inhibits Colonic Adenocarcinomas by Suppressing the p65/β-Catenin/Cyclin D1 Signaling Pathway in RatsCancer Prevention Research, 2011
- Screening Agents for Preventive Efficacy in a Bladder Cancer Model: Study Design, End Points, and Gefitinib and Naproxen EfficacyJournal of Urology, 2010
- Chemopreventive Efficacy of Naproxen and Nitric Oxide–naproxen in Rodent Models of Colon, Urinary Bladder, and Mammary CancersCancer Prevention Research, 2009
- Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitorsBMC Cancer, 2008
- Polyamines reverse non-steroidal anti-inflammatory drug-induced toxicity in human colorectal cancer cellsBiochemical Journal, 2003
- COX-2 inhibitorsThe Lancet, 1999
- Prostaglandins, their inhibitors and cancerProstaglandins, Leukotrienes & Essential Fatty Acids, 1996
- Mechanism of Action of Anti-Inflammatory DrugsScandinavian Journal of Rheumatology, 1996
- Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis.Annals Of The Rheumatic Diseases, 1974